EURO-STIM Registry
Launched by INSPIRE MEDICAL SYSTEMS, INC. · May 7, 2025
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The EURO-STIM Registry is a study designed to track how well the Inspire System works for people with Obstructive Sleep Apnea (OSA) over time. The Inspire System is a device that helps patients breathe better while they sleep. This registry will collect information during regular doctor visits to see how patients are doing with their treatment. Importantly, there are no special tests or treatments required for participants in this study.
To participate, patients must have the Inspire implant and be able to give their consent. They should also be willing to come back for routine check-ups to help manage their therapy. However, individuals with a life expectancy of less than one year or those deemed unfit by their doctor cannot join. The registry is not yet recruiting participants, but it aims to include all eligible patients, regardless of gender, aged 65 and older. This study will provide valuable insights into the long-term effectiveness and use of the Inspire System for treating OSA.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Any patient implanted with or receiving an Inspire implant, who meets the following criteria, is eligible to participate in the registry:
- • 1. Capable of giving informed consent, as required per institution
- • 2. Willing to return for routine clinic visits as required for Inspire therapy management
- Exclusion Criteria:
- Any patient who meets any of the following criteria will not be eligible to participate in the registry:
- • 1. Has a life expectancy of less than one year
- • 2. Any reason the clinician deems patient is unfit for participation in the study
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. is a pioneering medical technology company focused on transforming the treatment of obstructive sleep apnea (OSA) through innovative solutions. The company is dedicated to developing and commercializing implantable neurostimulation systems that stimulate the hypoglossal nerve to improve airway patency during sleep. With a commitment to advancing patient care and enhancing quality of life, Inspire Medical Systems engages in clinical trials to validate the safety and efficacy of its therapies, positioning itself at the forefront of sleep medicine. Through collaboration with healthcare providers and ongoing research, the company aims to deliver impactful solutions for individuals suffering from OSA.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported